High prevalence of Candida species in the respiratory tract of patients diagnosed with SARS-CoV-2
Canadian Journal of Microbiology · 2025
DOI: 10.1139/cjm-2025-0153 ↗Kurz gefasst
Fachartikel in der Zeitschrift Canadian Journal of Microbiology, 2025. Verfasst von Cristina de Castro Spadari und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil. Hauptthemen laut MEDLINE: COVID-19, Candida, Candidiasis, Respiratory System. Die Arbeit nennt 33 Literaturangaben. Gefördert von: Brazilian Ministry of Science, Technology and Innovation, São Paulo Research Support Foundation, National Council for Scientific and Technological Development.
Abstract (Originalsprache)
Coinfection and secondary infection by fungi in patients with viral pulmonary infection, especially SARS-CoV-2, are important factors that worsen the prognosis and are associated to increased death rates. This work aims to report the prevalence of Candida isolates in bronchoalveolar and nasopharyngeal samples from suspected COVID-19 patients in the first-second pandemic waves and their antifungal resistance profile. From 2321 patients, 29.04% were diagnosed with SARS-CoV-2 infection. The yeast isolation rate of 6.97% (47/674) from positive SARS-CoV-2 was statistically higher than 4.43% (73/1647) from negative SARS-CoV-2 patients ( p = 0.0177). Among yeasts, the most prevalent species was Candida albicans (63/120), with four being azole-resistant isolates (6.35%); however, other emerging and less susceptible species were also isolated, such as Candida guilliermondii (11), Candida glabrata (5), Candida lusitaniae (4), Candida krusei (1), and Candida norvegensis (1). Here, we highlighted Candida prevalence in respiratory tract, emphasizing the relevance for surveillance in SARS-CoV-2/COVID patients for improvement of management as well as patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
- Laboratory of Zoonoses and Vector-borne Diseases, Health Surveillance Coordination, São Paulo, Brazil.
- Hospital Israelita Albert Einstein, São Paulo, Brazil.
- Institut Pasteur de São Paulo, São Paulo, Brazil.
- Faculty of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil.
ORCID-Profile: Cristina de Castro Spadari, Nilton Lincopan, Kelly Ishida
Förderung
- Brazilian Ministry of Science, Technology and Innovation
- São Paulo Research Support Foundation
- National Council for Scientific and Technological Development
Zitieren
APA
Spadari, C., Esposito, F., Sano, E., Aires, C., Conselheiro, J., Barone, G., Reis-Menezes, A., de Oliveira, D., Luiz Durigon, E., Sampaio, J., Lincopan, N., & Ishida, K. (2025). High prevalence of Candida species in the respiratory tract of patients diagnosed with SARS-CoV-2. Canadian Journal of Microbiology. https://doi.org/10.1139/cjm-2025-0153
Vancouver
Spadari C, Esposito F, Sano E, Aires C, Conselheiro J, Barone G, et al. High prevalence of Candida species in the respiratory tract of patients diagnosed with SARS-CoV-2. Canadian Journal of Microbiology. 2025. doi:10.1139/cjm-2025-0153
BibTeX
@article{Spadari2025,
author = {Spadari, Cristina de Castro and Esposito, Fernanda Ribeiro Dos Santos and Sano, Elder and Aires, Caroline Cotrim and Conselheiro, Juliana Amorim and Barone, Gisely Toledo and Reis-Menezes, Adriana Araújo and de Oliveira, Danielle Bruna Leal and Luiz Durigon, Edison and Sampaio, Jorge M and Lincopan, Nilton and Ishida, Kelly},
title = {High prevalence of Candida species in the respiratory tract of patients diagnosed with SARS-CoV-2},
journal = {Canadian Journal of Microbiology},
year = {2025},
doi = {10.1139/cjm-2025-0153}
}
EUVIMED